|
|
|
| home > white papers > Protein Therapeutics - Reading Scientific Services Ltd (RSSL) |
|
|
 WHITE PAPERS |
|
Reading Scientific Services Ltd (RSSL)
|
|
Protein Therapeutics
|
|
The use of protein-based biological materials to treat patients suffering from a wide range of diseases is one of the success stories of modern medicine. The diseases treated include diabetes (insulin), growth hormone deficiencies (recombinant human growth hormone), inborn errors of metabolism (glucosylceramidase, alpha-galactosidase), and red blood cell deficiency (erythropoietin). As the market develops, the number of biopharmaceutical products both being submitted for regulatory approval and reaching the end of their patent life is increasing.
|
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
International biomed specialist appoints WHP to deliver key expansion project
New state of the art cleanroom facilities will enable a leading
international gene and cell therapy company to expand its bioprocessing
operations and manufacturing capabilities.
More info >> |
|
 |
White Papers |
 |
|
Translating Cancer Genomics Into A Personalised Approach For Cancer Patients
PRA Health Sciences (PRA)
Over the past few decades, the approach to prevention, diagnosis and treatment of cancer has radically shifted from organ-based to morphology-based and most recently, to genetics-based. Personalized or precision medicine (tailoring a treatment for a patient’s particular disease at a precise time point) is being performed every day at different levels in the clinical setting.
More info >> |
|
 |
Industry Events |
 |
PDA Europe Annual Meeting 2019
24 June 2019, Hilton Amsterdam
Featuring updates from international regulatory agencies as well as industry, this promises to become another highlight in the 2019 event calendar and is a meeting not to be missed!
More info >> |
|
|
|
